Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
Suleman Aktaa, Gorav Batra, John G F Cleland...
https://pubmed.ncbi.nlm.nih.gov/35443059/Actively Recruiting
Led by University Medical Center Ho Chi Minh City (UMC) · Updated on 2024-12-06
2500
Participants Needed
1
Research Sites
43 weeks
Total Duration
This research aims to describe the clinical features, biological markers, treatment, and cardiovascular events of patients with heart failure in Vietnam. It focuses on patients with reduced or mildly reduced heart function, specifically those with a left ventricular ejection fraction below 50%. The study is a prospective observational cohort that collects detailed demographic and clinical data from multiple cardiovascular centers. Patients hospitalized with heart failure will be included continuously during the study period. Data on their condition at discharge, including imaging results and treatments following national guidelines, will be collected. After discharge, participants will be followed up at 1, 3, and 12 months to gather information on their health status, medications, and any cardiovascular events such as rehospitalizations or deaths. Throughout the study, researchers will collect data using standardized definitions and a secure electronic database. Participants will be contacted periodically to update their medical history and treatment details. The main outcomes measured include all-cause mortality and heart failure rehospitalization within 12 months. Secondary outcomes include major cardiovascular events and adherence to guideline-directed therapy. The total participation duration spans from hospital discharge to one year of follow-up.
CONDITIONS
Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study
H
Hoang Vu Vu, MD, PhD
D
Dang Duy Quang Pham, MD, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Medical Center Ho Chi Minh City (UMC)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants who have been discharged with heart failure are observed for cardiovascular events and treatment status.
Visits approximately at 1 month, 3 months, and 12 months post-discharge
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Suleman Aktaa, Gorav Batra, John G F Cleland...
https://pubmed.ncbi.nlm.nih.gov/35443059/Theresa A McDonagh, Marco Metra, Marianna Adamo...
https://pubmed.ncbi.nlm.nih.gov/34447992/University Medical Center Ho Chi Minh City (UMC)
Lead Sponsor